Erythrocyte‐Leveraged Oncolytic Virotherapy (ELeOVt): Oncolytic Virus Assembly on Erythrocyte Surface to Combat Pulmonary Metastasis and Alleviate Side Effects

Abstract Despite being a new promising tool for cancer therapy, intravenous delivery of oncolytic viruses (OVs) is greatly limited by poor tumor targeting, rapid clearance in the blood, severe organ toxicity, and cytokine release syndrome. Herein, a simple and efficient strategy of erythrocyte‐lever...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mingyang Liu, Ruizhe Zhang, Hanwei Huang, Pengfei Liu, Xu Zhao, Hu Wu, Ying He, Ruizhe Xu, Xifeng Qin, Zhenguo Cheng, Hongyu Liu, Onder Ergonul, Füsun Can, Defang Ouyang, Zhenning Wang, Zhiqing Pang, Funan Liu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2024-02-01
Serie:	Advanced Science
Soggetti:	biocompatibility erythrocytes hitchhiking oncolytic virus targeted delivery
Accesso online:	https://doi.org/10.1002/advs.202303907
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!